Research & Development

超碰97超碰在线视频9797资源超碰在线视频北京今天傍晚至明天局地有暴雨 早高峰或受影响


  甦稚張開小巧的手掌,然後狠狠的捏成拳頭道︰“不管他是什麼樣的老賊,天不罰,我罰!”   直到跟雲瑯走了一遭戰場,被所有人當祖宗一樣的尊敬,才找回來了一點點的信心。超碰97   雲瑯下了樓,見閨女插著腰正在踢腿,就朝她招招手,閨女就鑽進了他的懷里。超碰在线视频97   “您要是去了,那個女婢就只有死路一條了,您的賠禮她還擔不起,長公主也不會允許您去道歉。”   “它們是在無恥的侵佔!”97资源超碰在线视频   “北方有佳人,絕世而獨立。一顧傾人城,再顧傾人國。寧不知傾城與傾國?佳人難再得……”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo